New hope for ruptured liver cancer: drug duo aims to stop recurrence after surgery
NCT ID NCT07331883
First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study tests whether combining two drugs (sintilimab and bevacizumab) after surgery can prevent liver cancer from coming back in patients whose tumor ruptured. About 35 adults with this rare, high-risk condition will receive the treatment. The goal is to see if this approach is safe and helps patients live longer without cancer returning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200031, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sanming First Hospital
NOT_YET_RECRUITINGSanming, Fujian, 365000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Third Bethune Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130033, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.